Release Date: November 14, 2025
Expiration Date: November 14, 2026
Activity Overview
This online, on-demand virtual symposium brings together renowned clinician-researchers in treating and managing COVID-19. In this educational program, these experts present evidence-based guidance on optimal patient selection and timing for pre-exposure prophylaxis (PrEP) and postexposure prophylaxis (PEP) interventions, the advantages and limitations of these approaches, and currently available options.
This educational activity is an archive of the live symposium held on October 7, 2025.
Target Audience
This educational activity is intended for family medicine physicians, primary care physicians, infectious disease specialists, critical care physicians, hospitalists, nurse practitioners, physician assistants, and pharmacists involved in the treatment and management of COVID-19.
Learning Objectives
Upon successful completion of this activity, you should be better prepared to:
- Describe the disease burden of COVID-19
- Evaluate emerging clinical trial data for current and investigational therapies in COVID-19 prophylaxis
- Formulate individualized treatment plans for the prophylaxis of COVID-19
Onyema Ogbuagu, MD, FACP, FIDSA
Director, Yale Antivirals and Vaccines Research Program
Associate Professor of Medicine and Pharmacology
Section of Infectious Diseases and Department of Pharmacology
Yale School of Medicine
New Haven, CT
Disclosures: Advisor, Consultant, Speaker, Honoraria Recipient: Gilead Sciences, Moderna
Jeffery A. Goad, PharmD, MPH
Professor of Pharmacy Practice
Chapman University School of Pharmacy
Chapman University
Irvine, CA
Disclosures: Advisor, Consultant, Speaker, Honoraria Recipient: Bavarian Nordic, Merck, Moderna, Valneva; Grant/Research Funding: Merck
William P. Hanage, PhD
Associate Professor of Epidemiology
Associate Director, Center of Communicable Disease Dynamics
Harvard University
Harvard T. H. Chan School of Public Health
Boston, MA
Disclosures: Advisor, Consultant, Speaker, Honoraria Recipient: Pfizer vaccines, Merck vaccines, Shionogi Inc
Faculty, Staff, and Planners’ Disclosures
The staff of Physicians’ Education Resource®, LLC, have no relevant financial relationships with ineligible companies.
PER® mitigated all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.
Off-Label Disclosure and Disclaimer
This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a health care professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.
GET STARTED WITH THIS PROGRAM:
Register now to gain access to this program.
Create AccountAlready Registered? Login Here